- Home
- PRTS vs ESLA Comparison
PRTS vs ESLA Comparison
Compare PRTS & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTS
- ESLA
- Stock Information
- Founded
- PRTS 1995
- ESLA 2021
- Country
- PRTS United States
- ESLA United States
- Employees
- PRTS N/A
- ESLA N/A
- Industry
- PRTS Auto & Home Supply Stores
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PRTS Consumer Discretionary
- ESLA Health Care
- Exchange
- PRTS Nasdaq
- ESLA Nasdaq
- Market Cap
- PRTS 47.8M
- ESLA 35.5M
- IPO Year
- PRTS 2007
- ESLA N/A
- Fundamental
- Price
- PRTS $0.88
- ESLA $1.01
- Analyst Decision
- PRTS Buy
- ESLA Strong Buy
- Analyst Count
- PRTS 2
- ESLA 1
- Target Price
- PRTS $1.40
- ESLA $16.00
- AVG Volume (30 Days)
- PRTS 708.7K
- ESLA 23.1K
- Earning Date
- PRTS 05-13-2025
- ESLA 05-14-2025
- Dividend Yield
- PRTS N/A
- ESLA N/A
- EPS Growth
- PRTS N/A
- ESLA N/A
- EPS
- PRTS N/A
- ESLA N/A
- Revenue
- PRTS $569,935,000.00
- ESLA N/A
- Revenue This Year
- PRTS $1.73
- ESLA $101.09
- Revenue Next Year
- PRTS $5.48
- ESLA N/A
- P/E Ratio
- PRTS N/A
- ESLA N/A
- Revenue Growth
- PRTS N/A
- ESLA N/A
- 52 Week Low
- PRTS $0.68
- ESLA $0.63
- 52 Week High
- PRTS $1.45
- ESLA $3.23
- Technical
- Relative Strength Index (RSI)
- PRTS 51.24
- ESLA 50.50
- Support Level
- PRTS $0.80
- ESLA $0.97
- Resistance Level
- PRTS $0.94
- ESLA $1.04
- Average True Range (ATR)
- PRTS 0.06
- ESLA 0.06
- MACD
- PRTS 0.01
- ESLA -0.00
- Stochastic Oscillator
- PRTS 67.32
- ESLA 63.27
About PRTS CarParts.com Inc.
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.